Altered expression of genes controlling metabolism characterizes the tissue response to immune injury in lupus

Sci Rep. 2021 Jul 20;11(1):14789. doi: 10.1038/s41598-021-93034-w.

Abstract

To compare lupus pathogenesis in disparate tissues, we analyzed gene expression profiles of human discoid lupus erythematosus (DLE) and lupus nephritis (LN). We found common increases in myeloid cell-defining gene sets and decreases in genes controlling glucose and lipid metabolism in lupus-affected skin and kidney. Regression models in DLE indicated increased glycolysis was correlated with keratinocyte, endothelial, and inflammatory cell transcripts, and decreased tricarboxylic (TCA) cycle genes were correlated with the keratinocyte signature. In LN, regression models demonstrated decreased glycolysis and TCA cycle genes were correlated with increased endothelial or decreased kidney cell transcripts, respectively. Less severe glomerular LN exhibited similar alterations in metabolism and tissue cell transcripts before monocyte/myeloid cell infiltration in some patients. Additionally, changes to mitochondrial and peroxisomal transcripts were associated with specific cells rather than global signal changes. Examination of murine LN gene expression demonstrated metabolic changes were not driven by acute exposure to type I interferon and could be restored after immunosuppression. Finally, expression of HAVCR1, a tubule damage marker, was negatively correlated with the TCA cycle signature in LN models. These results indicate that altered metabolic dysfunction is a common, reversible change in lupus-affected tissues and appears to reflect damage downstream of immunologic processes.

Publication types

  • Comparative Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Citric Acid Cycle
  • Databases, Genetic
  • Disease Models, Animal
  • Female
  • Gene Expression Profiling / methods*
  • Gene Expression Regulation
  • Gene Regulatory Networks*
  • Glucose / metabolism
  • Glycolysis
  • Humans
  • Interferon Type I / adverse effects
  • Lipid Metabolism
  • Lupus Erythematosus, Discoid / genetics*
  • Lupus Erythematosus, Discoid / metabolism
  • Lupus Nephritis / genetics*
  • Lupus Nephritis / metabolism
  • Mice

Substances

  • Interferon Type I
  • Glucose